Advertisement
Screener

Kiromic Biopharma, Inc. Shareholders' Equity

Kiromic Biopharma, Inc. Shareholders' Equity

Kiromic Biopharma, Inc. had Shareholders' Equity of -$12.59 million as of 2024-12-31, per its 10-K filed 2025-02-14.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:StockholdersEquity · last filed 2025-02-14

  • 2024-12-31: Stockholders' Equity Attributable to Parent -$12.59M.
  • 2024-09-30: Stockholders' Equity Attributable to Parent -$9.29M.
  • 2024-06-30: Stockholders' Equity Attributable to Parent -$5.17M; Stockholders' Equity Attributable to Parent as first filed -$5.17M.
  • 2024-03-31: Stockholders' Equity Attributable to Parent -$7.21M; Stockholders' Equity Attributable to Parent as first filed -$7.21M.
Period endStockholders' Equity Attributable to ParentStockholders' Equity Attributable to Parent as first filed
2024-12-31-$12.59M
10-K · filed 2025-02-14
2024-09-30-$9.29M
10-Q · filed 2024-11-08
2024-06-30-$5.17M
10-Q · filed 2024-11-08
-$5.17M
10-Q · filed 2024-08-09
2024-03-31-$7.21M
10-Q · filed 2024-11-08
-$7.21M
10-Q · filed 2024-05-10
2023-12-31-$9.12M
10-K · filed 2025-02-14
-$9.12M
10-K · filed 2024-03-19
2023-09-30-$4.49M
10-Q · filed 2024-11-08
-$4.49M
10-Q · filed 2023-11-14
2023-06-30-$6.29M
10-Q · filed 2024-11-08
-$6.29M
10-Q · filed 2023-08-14
2023-03-31-$8.14M
10-Q · filed 2024-11-08
-$8.14M
10-Q · filed 2023-05-15
2022-12-31-$5.78M
10-K · filed 2025-02-14
-$5.77M
10-K · filed 2023-04-17
2022-09-30$284.10K
10-Q · filed 2023-11-14
2022-06-30$11.78M
10-Q · filed 2023-11-14
2022-03-31$20.03M
10-Q · filed 2023-11-14
2021-12-31$27.32M
10-K · filed 2024-03-19
2021-09-30$37.51M
10-Q · filed 2022-11-14
2021-06-30$4.87M
10-Q · filed 2022-11-14
2021-03-31$8.45M
10-Q · filed 2022-11-14
2020-12-31$11.36M
10-K · filed 2023-04-17
2020-09-30$928.60K
10-Q · filed 2022-03-11
2020-06-30$2.10M
10-Q · filed 2022-03-11
2020-03-31$3.58M
10-Q · filed 2022-03-11
2019-12-31$1.98M
10-K · filed 2022-04-08
2019-09-30$679.00K
10-Q · filed 2020-11-30
2019-06-30-$197.00K
10-Q · filed 2020-11-30
2019-03-31-$21.60K
10-Q · filed 2020-11-30
2018-12-31$265.30K
10-K · filed 2021-03-31